NASDAQ:SNCE Science 37 (SNCE) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free SNCE Stock Alerts $5.75 +0.02 (+0.35%) (As of 03/12/2024) Add Compare Share Share Today's Range$5.73▼$5.7550-Day Range$4.74▼$5.7552-Week Range$3.73▼$12.96Volume49,100 shsAverage Volume43,227 shsMarket Capitalization$34.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Science 37 alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Science 37 Stock (NASDAQ:SNCE)Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.Read More SNCE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SNCE Stock News HeadlinesMarch 12, 2024 | prnewswire.comeMed completes tender offer for all outstanding shares of Science 37February 27, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEMarch 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.February 12, 2024 | finance.yahoo.comeMed commences tender offer for Science 37February 10, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEFebruary 10, 2024 | markets.businessinsider.comScience 37 Initiates Cost-Cutting, Workforce Reduction PlanFebruary 4, 2024 | morningstar.comScience 37 Holdings Inc SNCEFebruary 1, 2024 | benzinga.comScience 37 Hldgs Stock (NASDAQ:SNCE) Dividends: History, Yield and DatesMarch 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.January 31, 2024 | stockhouse.comShareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMedJanuary 30, 2024 | msn.comScience 37 Issues Regulation FD Informational DisclosureJanuary 30, 2024 | msn.comScience 37 Announces Upcoming Merger Agreement ExecutionJanuary 30, 2024 | realmoney.thestreet.comScience 37 just downgraded at Craig-Hallum, here's whyJanuary 29, 2024 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Science 37 Holdings, Inc. BuyoutJanuary 29, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Science 37 (SNCE), Avid Bioservices (CDMO)January 29, 2024 | benzinga.comCrude Oil Down Over 1%; Science 37 Holdings Shares Spike HigherJanuary 29, 2024 | tmcnet.comSNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to ShareholdersJanuary 29, 2024 | finanznachrichten.deScience 37, Inc.: Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating EnrollmentJanuary 29, 2024 | marketwatch.comScience 37 Shares Rise on Deal to Be AcquiredDecember 28, 2023 | seekingalpha.comNDRA, LITM and SNCE among mid-day moversDecember 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q3 2023December 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q2 2023December 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q1 2023December 12, 2023 | finance.yahoo.comScience 37 Receives Top Honors in Everest PEAK Matrix®December 5, 2023 | finance.yahoo.comScience 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023November 12, 2023 | finance.yahoo.comScience 37 Holdings, Inc. (NASDAQ:SNCE) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | finance.yahoo.comIt's Down 28% But Science 37 Holdings, Inc. (NASDAQ:SNCE) Could Be Riskier Than It LooksSee More Headlines Receive SNCE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:SNCE CUSIPN/A CIK1819113 Webwww.lifesciacquisition.com Phone984-377-3737FaxN/AEmployees460Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($21.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,990,000.00 Net Margins-206.86% Pretax Margin-207.00% Return on Equity-83.09% Return on Assets-61.58% Debt Debt-to-Equity RatioN/A Current Ratio4.17 Quick Ratio4.17 Sales & Book Value Annual Sales$60.26 million Price / Sales0.57 Cash FlowN/A Price / Cash FlowN/A Book Value$16.70 per share Price / Book0.34Miscellaneous Outstanding Shares5,970,000Free Float5,564,000Market Cap$34.33 million OptionableNot Optionable Beta0.55 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. David Coman (Age 54)CEO & Director Comp: $796.13kMs. Christine A. Pellizzari J.D. (Age 56)Chief Legal & Human Resources Officer and Secretary Comp: $521.58kMs. Darcy Forman (Age 48)Chief Delivery Officer Comp: $550.58kMr. Mike Zaranek (Age 53)Chief Financial Officer Irena LambridisVP and Head of Quality Assurance & ComplianceMs. Margie Gimbel KoomanVice President of Marketing & CommunicationsMr. Drew BustosChief Strategy & Marketing OfficerMr. Jonathan Cotliar M.D. (Age 52)Chief Medical Officer Comp: $486.6kMr. Michael Shipton (Age 52)Chief Commercial Officer Mr. Tyler Van HornVP of Corporate Strategy & Chief of StaffMore ExecutivesKey CompetitorsbioAffinity TechnologiesNASDAQ:BIAFAIkido PharmaNASDAQ:AIKIAkuminNASDAQ:AKUMQTheratechnologiesNASDAQ:THTXCortexymeNASDAQ:CRTXView All CompetitorsInstitutional OwnershipVanguard Group Inc.Sold 3,067,329 shares on 3/11/2024Ownership: 2.686%Vanguard Group Inc.Sold 3,067,329 shares on 2/15/2024Ownership: 2.686%Citadel Advisors LLCSold 1,349,111 shares on 2/15/2024Ownership: 1.133%Kent Lake Capital LLCSold 805,911 shares on 2/14/2024Ownership: 4.666%Verition Fund Management LLCSold 352,762 shares on 2/14/2024Ownership: 0.308%View All Institutional Transactions SNCE Stock Analysis - Frequently Asked Questions Should I buy or sell Science 37 stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Science 37 in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNCE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNCE, but not buy additional shares or sell existing shares. View SNCE analyst ratings or view top-rated stocks. How have SNCE shares performed in 2024? Science 37's stock was trading at $5.34 at the start of the year. Since then, SNCE shares have increased by 7.7% and is now trading at $5.75. View the best growth stocks for 2024 here. Are investors shorting Science 37? Science 37 saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 13,800 shares, a drop of 56.9% from the February 14th total of 32,000 shares. Based on an average daily trading volume, of 52,900 shares, the short-interest ratio is currently 0.3 days. Currently, 0.2% of the company's shares are short sold. View Science 37's Short Interest. When did Science 37's stock split? Science 37 shares reverse split before market open on Friday, December 8th 2023. The 1-20 reverse split was announced on Friday, December 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Science 37's major shareholders? Science 37's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Kent Lake Capital LLC (4.67%), Glynn Capital Management LLC (2.96%), Russell Investments Group Ltd. (2.84%), Vanguard Group Inc. (2.69%), Vanguard Group Inc. (2.69%) and Citadel Advisors LLC (1.13%). View institutional ownership trends. How do I buy shares of Science 37? Shares of SNCE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SNCE) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Science 37 Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.